Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017
SAN JOSE, Calif., Oct. 17, 2017 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI) today announced it will release its financial results for the third quarter of 2017 on Thursday, November 2, 2017 after the close of the market. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 2:00 p.m. Pacific Time with Chris Kramer, president and chief executive officer and Bill Roeschlein, chief financial officer.
To participate via telephone, the toll free dial-in number is (877) 251-1860; international callers should dial (224) 357-2386. The conference ID number is 95697975. Please dial in 10 minutes prior to the scheduled conference call time. A live and archived audio only webcast will be available on Intermolecular's website at http://ir.intermolecular.com for up to 30 days after the call.
About Intermolecular, Inc.
Intermolecular® is the trusted partner for advanced materials innovation. Advanced materials are at the core of innovation in the 21st century for a wide range of industries including semiconductors, consumer electronics, automotive and aerospace. With its substantial materials expertise; accelerated learning and experimentation platform; and information and analytics infrastructure, Intermolecular has a ten-year track record helping leading companies accelerate and de-risk materials innovation.
"Intermolecular" and the Intermolecular logo are registered trademarks; all rights reserved. Learn more at www.intermolecular.com.
Contacts
Bill Roeschlein Intermolecular, Inc. Chief Financial Officer [email protected] +1.408.582.5415
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...